Recent

% | $
Quotes you view appear here for quick access.

Dish Network Corp. Message Board

seekingprofits247 105 posts  |  Last Activity: 10 hours ago Member since: Jan 31, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • seekingprofits247 seekingprofits247 10 hours ago Flag

    This article, Walking index for spinal cord injury (WISCI): criterion validation is the basis for slide 32. The paper is very interesting read....

    "The strong correlations of the ASIA grades with the WISCI levels (Table 4a and b) further support the construct validity of the scale. The highest correlation is for subjects who are ASIA C and D, thus demonstrating that the WISCI scale primarily is applicable to these subjects and to some ASIA A and B who convert to C.

  • Search for "Spinal Cord Injury Rehabilitation Functional Expectations and Ambulation Potential" and go to slide 32 and find out what the Shepherd Center has to say....or I'll save you some time...

    AIS A: 6.4%
    AIS B: 23.5%
    AIS C: 51.4%
    AIS D: 88.6%

    The presentation has some good information.

    Sentiment: Strong Buy

  • Reply to

    Fein wrote.....

    by alexsissy Apr 24, 2015 1:27 PM
    seekingprofits247 seekingprofits247 Apr 24, 2015 1:36 PM Flag

    I am just waiting for the first earnings call they have. Earnings releases in the past, 2014-05-12, 2013-05-09, 2012-05-14, and 2011-05-16.

    Sentiment: Strong Buy

  • Reply to

    Putting Jesi's fantastic recovery in perspective

    by levuccio Apr 23, 2015 4:17 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 12:58 PM Flag

    To quote someone, "Great times ahead."

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 12:46 PM Flag

    IMO there's actually someone I believe who is even more confident, Lorianne Masuoka, MD
    Chief Medical Officer, "Prior to joining the InVivo team, Dr. Masuoka served as Senior Vice President and Chief Medical Officer at Cubist Pharmaceuticals from July 2013 until Jan 2015".

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 12:41 PM Flag

    What tripped us up last time was a governance issue. We had all the requisite committees. We just need the price. NVIV used the same play book as BCLI, but NVIV's result were even faster.

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 12:38 PM Flag

    NVIV announced uplist intentions on March 24th. We uplisted on April 17th.

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:35 AM Flag

    I got a response in less than one MINUTE telling me it would be taken up to management

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:28 AM Flag

    To quote someone "Great times ahead."

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:24 AM Flag

    Again, so why didn't they uplist when they had Patient 1's AIS C data at 1 month and could release the data 3 months later?

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:21 AM Flag

    So why didn't they uplist when they had Patient 1's AIS C data at 1 month?

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:19 AM Flag

    No idea.

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:18 AM Flag

    I don't believe he would have uplisted with bad data from patient #2. I emailed the company on why the company hadn't uplisted in that it should uplist because I anticipated good efficacy data coming throughout 2015. I did this in January. Patient 1's AIS C was based on B&B at 1 month, not videos you saw in January.

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:09 AM Flag

    You have your opinion, but my opinion is based on history. If you go back and look at the events based on what we now know about Jordan's AIS C grade at one month, you will see significant changes were made by the company around this time.

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:06 AM Flag

    Perrin is sticking to the official time table. I emailed about releasing data at one month. I got a response in less than one month telling me it would be taken up to management. I sent the email on a Sunday.It is obvious that Perrin said no. I think he is conservative which I can appreciate. Patient 2's 3 month data will be released in line with patient 1's 3 month data.

    Sentiment: Strong Buy

  • Reply to

    Perrin's Thoughts on Video

    by seekingprofits247 Apr 24, 2015 9:42 AM
    seekingprofits247 seekingprofits247 Apr 24, 2015 10:01 AM Flag

    If Perrin truly wanted to play investors, and this comment is really going to blow the shorts away, Perrin would have uplisted prior to Jordan's 3 month data because he had the AIS C data in hand prior to 1 month. But he decided to find ways to shortened the trial verses go for the Nasdaq. We instead get an announcement on October 29th about the broadening of the trial. Why? Because they already knew what was going on with Jordan prior to 1 month. His month assessment wouldn't have taken place until around November 13th!!!!

    My guess is that Perrin didn't want to uplist so that he could work with the FDA on shortening this trial and he didn't want to worry about dealing with Jesi's results if they were negative. That's not the case and that is why he uplisted. Again I will quote someone, "Great times ahead."

    Sentiment: Strong Buy

  • seekingprofits247 by seekingprofits247 Apr 24, 2015 9:42 AM Flag

    “These are young adults. They are on social media,” he [Perrin] said. But he said the attention – so far overwhelming positive – hasn't affected the ongoing clinical trials of the potential treatment. "THE ONLY THING THE FDA CARES ABOUT IS CLINICAL DATA. IT’S GOT TO BE DATA-DRIVEN, NOT VIDEO-DRIVEN.”

    Anyone that read Sieffert's April 20th article but didn't read his April 16th article needs to weigh the two articles together. I don’t understand why JNap truly believes that Perrin didn't have Jesi's data in hand before making this move to uplist.

    March 24th the company announces it will uplist. Two months after Jesi's surgery. Why? Perrin had the one month data or more for Jesi in hand. Do people who short this stock really think Perrin and other company officials only talk to these doctors based on the schedule in the investor presentation? Why would Perrin uplist for what JNap percieves to be an AIS A patient? Wouldn't Perrin know that Jesi is AIS A at the two month mark? My observations are that this move by Perrin is like the BCLI and CTIX CEOs. All 3 companies have solid data and that was the reason they decided to uplist. Not "look at us we're on the Nasdaq." If anything that anyone that follows the company in detail has learned, they know Perrin is hyper-conservative and would not uplist to only have the stock price drop like a rock because Jesi is AIS A. You can’t attract institutional investors using that type of plan. My advice to people who short this stock, once Jesi's data is released you should seriously consider stop shorting this stock as the odds will be against you.

    To quote someone, "Great times ahead."

    Sentiment: Strong Buy

  • seekingprofits247 seekingprofits247 Apr 24, 2015 9:25 AM Flag

    The company officially collects data at these intervals.

    Frequent safety and effectiveness assessments
    – 24, 48, 72 hours; 1 week; acute care discharge; 1, 3, 6, and 12 months.

    They officially release data at 3 and 6. Jordan's 1 month data made him AIS C, not his 3 month data. Again, 2 months after Jesi has surgery, they announce they will uplist. Sometimes one + one equals two.

    Sentiment: Strong Buy

  • seekingprofits247 seekingprofits247 Apr 24, 2015 9:04 AM Flag

    “These are young adults. They are on social media,” he [Perrin] said. But he said the attention – so far overwhelming positive – hasn't affected the ongoing clinical trials of the potential treatment. "THE ONLY THING THE FDA CARES ABOUT IS CLINICAL DATA. IT’S GOT TO BE DATA-DRIVEN, NOT VIDEO-DRIVEN.”

    You love Sieffert's April 20th article but you didn't read his April 16th article. You need to weigh the two articles together. Do you and JNap truly believe that Perrin didn't have Jesi's data in hand before making this move to uplist?

    March 24th the company announces it will uplist. Two months after Jesi's surgery. Why? Why? Because they had the one month data or more for Jesi in hand. Do you really think the Perrin and company only talk to these doctors based on the schedule in the investor presentation? Why would Perrin uplist for what JNap percieves to be an AIS A patient? Wouldn't Perrin know that she is AIS A at the two month mark? My observations is that this move by Perrin, is like the BCLI and CTIX CEOs. All 3 companies have solid data and that was the reason they up-listed. Not "look at us we're on the Nasdaq." If anything that anyone that follows the company in detail has learned, they know Perrin is hyper-conservative and would not uplist to only have the stock price drop like a rock because Jesi is AIS A. My advice to you once Jesi's data is released is that you seriously consider stop shorting this stock as the odds will be against you. Join the dark side of the force--join the longs.

    Sentiment: Strong Buy

  • seekingprofits247 seekingprofits247 Apr 24, 2015 7:16 AM Flag

    Good, I can feel your anger. I am defenseless. Take your short position. Strike me down with all of your hatred and your journey towards the long side will be complete!

    Sentiment: Strong Buy

DISH
69.91+0.31(+0.44%)Apr 24 4:00 PMEDT